CATX
Perspective Therapeutics, Inc.
Key Financials
Gross Profit
$1.4M
↑ Infinity%
Revenue
$2.5M
↓ 13.9%
Net Income
$-103121000
↓ 30.1%
Operating Income
$-113564000
↓ 25.0%
EPS (Diluted)
$-1.40
↓ 13.8%
Total Liabilities
$59.9M
↑ 18.9%
Cash & Equivalents
$30.6M
↓ 50.3%
Total Assets
$267.0M
↓ 21.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CATX |
| Company Name | Perspective Therapeutics, Inc. |
| CIK | 728387 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 206-676-0900 |